See more : ESGold Corp. (ESAU.CN) Income Statement Analysis – Financial Results
Complete financial analysis of Irwin Naturals Inc. (IWIN.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Irwin Naturals Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- The Greater Cannabis Company, Inc. (GCAN) Income Statement Analysis – Financial Results
- Guangdong Adway Construction (Group) Holdings Company Limited (6189.HK) Income Statement Analysis – Financial Results
- Thirani Projects Limited (TPROJECT.BO) Income Statement Analysis – Financial Results
- Thai Oil Public Company Limited (TOP.BK) Income Statement Analysis – Financial Results
- Strateco Resources Inc. (SRSIF) Income Statement Analysis – Financial Results
Irwin Naturals Inc. (IWIN.CN)
About Irwin Naturals Inc.
Irwin Naturals Inc., a herbal supplement company, distributes CBD products in the United States and internationally. It offers its products online, as well as through approximately 100,000 stores. The company was formerly known as Datinvest International Ltd. The company is based in Los Angeles, California.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 89.47M | 100.34M | 89.38M | 87.86M |
| Cost of Revenue | 48.73M | 55.65M | 52.88M | 48.87M |
| Gross Profit | 40.74M | 44.69M | 36.50M | 38.99M |
| Gross Profit Ratio | 45.54% | 44.54% | 40.84% | 44.37% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 38.48M | 34.12M | 28.90M | 32.68M |
| Other Expenses | 421.00K | -2.51M | 0.00 | 0.00 |
| Operating Expenses | 38.90M | 34.12M | 28.90M | 32.60M |
| Cost & Expenses | 87.63M | 89.77M | 81.77M | 81.47M |
| Interest Income | 0.00 | 131.00K | 10.00K | 398.00K |
| Interest Expense | 767.00K | 131.00K | 312.00K | 0.00 |
| Depreciation & Amortization | 1.81M | 1.43M | 1.36M | 852.00K |
| EBITDA | 1.60M | 10.69M | 9.07M | 6.52M |
| EBITDA Ratio | 1.79% | 11.96% | 10.09% | 7.42% |
| Operating Income | 1.84M | 10.57M | 7.66M | 6.31M |
| Operating Income Ratio | 2.06% | 10.53% | 8.57% | 7.18% |
| Total Other Income/Expenses | -2.81M | -2.64M | -302.00K | -320.00K |
| Income Before Tax | -970.00K | 7.93M | 7.36M | 5.99M |
| Income Before Tax Ratio | -1.08% | 7.90% | 8.23% | 6.82% |
| Income Tax Expense | 1.55M | -2.19M | 116.00K | 74.00K |
| Net Income | -3.99M | 8.62M | 7.24M | 5.92M |
| Net Income Ratio | -4.46% | 8.59% | 8.10% | 6.73% |
| EPS | -2.79 | 7.18 | 5.94 | 5.92 |
| EPS Diluted | -2.79 | 0.03 | 5.94 | 5.92 |
| Weighted Avg Shares Out | 1.43M | 321.22M | 1.22M | 999.16K |
| Weighted Avg Shares Out (Dil) | 1.43M | 321.22M | 1.22M | 999.16K |
Source: https://incomestatements.info
Category: Stock Reports